Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
Vineet Laboratories Ltd.
₹33.50
₹33.39
₹34.17
₹24.01
₹43.50
Markets Today
Historical Performance
As of 09-06-2026 22:48, Vineet Laboratories Ltd. share price today is ₹0, with a change of ₹-33.39 (-100.00%) from the previous close of ₹33.39. The stock opened at ₹33.39 and traded between ₹33.39 and ₹34.17, with a total traded volume of 13503 shares. The company has a market capitalization of ₹64.7 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹43.5 and ₹24.01, respectively.
Vineet Laboratories Ltd. valuation metrics include a P/E ratio of -6.4, and book value of ₹2.60. Profitability indicators show ROE of -137.84%. Vineet Laboratories Ltd. has reported revenue of ₹54.59 Cr and net profit of ₹-10.14 Cr.
Vineet Laboratories Ltd. technical indicators include Day RSI at 42.91, Day MFI at 58.49, Day ADX at 14.69. Additional indicators include Commodity Channel Index (CCI) at -91.6 and Williams %R at -88.91. Momentum indicators show Day MACD at -0.38, Day MACD Signal Line at -0.19, DayATR at 1.76. Rate of Change indicators for Vineet Laboratories Ltd. include ROC125 at -5.75 and ROC21 at -15.66.
Exponential moving averages include EMA5 at ₹34.2, EMA10 at ₹34.5, EMA12 at ₹34.6, EMA20 at ₹34.9, EMA26 at ₹35, EMA50 at ₹34.6, EMA100 at ₹34, EMA200 at ₹33.8. Simple moving averages include SMA5 at ₹34.3, SMA10 at ₹34.5, SMA20 at ₹34.9, SMA30 at ₹36, SMA50 at ₹34.7, SMA100 at ₹33.2, SMA150 at ₹34.3, SMA200 at ₹33.6.
Support levels for Vineet Laboratories are placed at First Support ₹32.73, Second Support ₹32.06, Third Support ₹30.98. Resistance levels are seen at First Resistance ₹34.48, Second Resistance ₹35.56, Third Resistance ₹36.23. Vineet Laboratories Ltd. shareholding pattern shows promoter holding at 5.98%, FII holding at 0.36%, DII holding at 0%, public holding at 93.67%.
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 15.65 | 17.42 | 7.44 | 14.08 | 18.10 |
| Operating Expense | 13.16 | 14.24 | 7.12 | 25.12 | 22.24 |
| Operating Profit | 2.49 | 3.18 | 0.32 | -11.05 | -4.14 |
| Depreciation | 0.63 | 0.63 | 0.63 | 0.66 | 0.62 |
| Interest | 1.09 | 2.19 | 0.61 | 0.90 | 0.95 |
| Tax | -0.03 | -0.03 | -0.04 | -0.70 | 0.03 |
| Net Profit | 0.85 | 0.40 | -0.87 | -10.53 | -5.71 |
₹33.50
↗ Bullish Moving Average
2
↘ Bearish Moving Average
14
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 35.8 | 35.8 | 29.3 | 15.9 | 12.5 | 6 |
| FII | 0 | 0 | 0 | 0 | 0 | 0.4 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 64.2 | 64.2 | 70.7 | 84.1 | 87.5 | 93.7 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 43.69 K | 43.69 K | 100.00% |
| Week | 53.2 K | 53.2 K | 100.00% |
| 1 Month | 59.1 K | 59.1 K | 100.00% |
| 6 Month | 68.67 K | 1.08 L | 63.62% |
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with 10% increase in share price over three months, with rising net profit growth
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over 1 Year
PEG lower than Industry PEG
Growth in Net Profit with increasing Profit Margin (QoQ)
Increasing profits every quarter for the past 3 quarters
Company able to generate Net Cash - Improving Net Cash Flow for last 2 years
Companies with Zero Promoter Pledge
Stock with Low PE (PE < = 10)
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 19 Sep, 2022 | 1 | FINAL | 20 Sep, 2022 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹558.75 | ₹6.16 | ₹136.48 | ₹15.10 | ₹563.90 | ₹1,095 |
| % Change | 1.42% | -1.12% | 4.30% | 7.40% | 1.25% | 8.74% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | ₹287.68 | ₹176.50 | ₹502.55 | ₹649.50 |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | ₹14.88 | ₹27.81 | ₹57.92 | ₹115.38 |
| PE TTM | - | -1.50 | 35.40 | 28.90 | 28.00 | 43.70 |
| 1 Year Return | 42.87 | 515 | 7.51 | 66.37 | -21.47 | 105.39 |
| ROCE | 3.56 | -5.63 | - | 17.36 | 23.87 | 15.60 |
Innova Captab Ltd.
₹ 917.10
+5.41%
Valiant Laboratories Ltd.
₹ 73.00
-1.27%
Sigachi Industries Ltd.
₹ 21.27
+0.76%
Windlas Biotech Ltd.
₹ 830.00
+1.94%
Solara Active Pharma Sciences Ltd.
₹ 574.00
+9.35%
Zim Laboratories Ltd.
₹ 113.05
+5.00%
Medico Remedies Ltd.
₹ 42.82
-1.95%
Dishman Carbogen Amcis Ltd.
₹ 189.00
+2.51%
Lasa Supergenerics Ltd.
₹ 7.61
-0.65%
Advanced Enzyme Technologies Ltd.
₹ 373.30
+0.35%
Bajaj Healthcare Ltd.
₹ 290.05
-0.17%
Ortin Global Ltd.
₹ 17.93
-9.99%
Brooks Laboratories Ltd.
₹ 69.00
+3.51%
RPG Life Sciences Ltd.
₹ 2110.10
+1.01%
Bafna Pharmaceuticals Ltd.
₹ 174.58
-10.00%
Alpa Laboratories Ltd.
₹ 69.80
+2.29%
SMS Pharmaceuticals Ltd.
₹ 380.00
+3.04%
Nectar Lifesciences Ltd.
₹ 11.60
-0.34%
Mangalam Drugs and Organics Ltd.
₹ 28.40
-0.18%
Indoco Remedies Ltd.
₹ 207.00
+3.74%
Ind-Swift Laboratories Ltd.
₹ 163.70
+4.44%
Lincoln Pharmaceuticals Ltd.
₹ 635.50
+2.53%
Panacea Biotec Ltd.
₹ 612.00
+10.69%
By signing up I certify terms, conditions & privacy policy